Select Page

The return on my Jubak Picks Portfolio
from May 1997 through the end of 2019: 584%
ArrowCircle100

Jubak’s Picks

Stocks for a 12-18 Month Horizon


Performance

2019
+10.2%

2018
+10.2%

2017
+13.2%

Since Inception
+584%

Top 50 Stocks

50 Best Stocks in the World


Performance

2019
+21.19%

2018
-8.22%

2017
+28.1%

2016
+21.5%

Dividend Income

Stocks that Pay You


Performance

2021
+18.59%

2020
+15.71%

2019
+4.90%

2018
-15.52%

2017
+6.48%

2016
+26.8%

Best in Business Award

Archives

Sign Up or Sign In to View Jim's Extras

Inflation, especially services inflation, looks sticky: PCE inflation up a fast 0.4% month to month in January

Inflation, especially services inflation, looks sticky: PCE inflation up a fast 0.4% month to month in January

The headline, all-items Personal Consumption Expenditures price index, the Federal Reserve’s preferred inflation measure, climbed at a 2.4% year over year rate in January. That was in line with what economists had forecast and down from the 2.6% annual rate in December. The core PCE, that is after stripping out more volatile food and fuel prices, climbed at a 2.8% year over year rate. In December the annual rate of core inflation had been 2.9%. But that was the end of the good news in today’s PCE inflation report.

read more
Need more GLP? Buying Viking Therapeutics on trial results

Need more GLP? Buying Viking Therapeutics on trial results

Yesterday, February 28, development-stage biotech Viking Therapeutics (VKTX) announced results from a Phase 2 training of its GLP-1 weight-loss drug candidate that that showed the potential for the VK2735 compound two move to be best in class in the $36.5 billion (revenue) market for GLP diabetes-control and weight-loss drugs. I will add Viking Therapeutic to my Volatility Portfolio and to my Jubak’s Picks Portfolio today, February 29, with a target price of $150.

read more
Nvidia lifts most but not all tech boats

Nvidia lifts most but not all tech boats

Yesterday, Thursday, February 22, Nvidia (NVDA) gained 16.40% at the close after beating Wall Street expectations on earnings and revenue after the market close on Wednesday. And then raising guidance for the rest of 2024. But what most interested me on Thursday were what tech stocks Nvidia carried higher with it–and which stocks it didn’t.

read more
Yes, I’d buy Palo Alto Networks today–with these caveats

Yes, I’d buy Palo Alto Networks today–with these caveats

After yesterday’s earnings report–the company beat Wall Street estimates for the quarter–and radically lower guidance for next quarter and the rest of 2024–total billings for next quarter will grow by just 2% to 4% and revenue for all of 2024 will grow by just 15% to 16% from 2023–shares of Palo Alto Networks (PANW) took a big hit right between the eyes. The stock fell 28.44% at the close and lost $104.12 a share to $261.97. What do I recommend? I’d say “buy” with a couple of caveats. Why buy?

read more

Jim’s Daily Email Alerts

Every post from Jubak Picks straight to your mailbox. And they're free!

Download Jim’s NEWEST eBook


Keyword Tags